<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>MSF Topic:</title>
    <link>http://hdl.handle.net/10144/10947</link>
    <description />
    <pubDate>Tue, 21 May 2013 23:54:31 GMT</pubDate>
    <dc:date>2013-05-21T23:54:31Z</dc:date>
    <item>
      <title>Challenges and Opportunities for the Implementation of Virological Testing in resource-limited settings</title>
      <link>http://hdl.handle.net/10144/280932</link>
      <description>Title: Challenges and Opportunities for the Implementation of Virological Testing in resource-limited settings
Authors: Roberts, Teri; Bygrave, Helen; Fajardo, Emmanuel; Ford, Nathan
Abstract: Though the advantages of routine virological monitoring for patients on anti-retroviral therapy have been established, cost and complexity limit its full implementation. Monitoring is important for diagnosing virological failure early on, before the development of drug resistance mutations, and to trigger early adherence interventions. Simple and cost-effective viral load tests that facilitate simplification and decentralization of testing and strategies, such as the use of dried blood spots and pooled sample testing, which further aid simplification, are becoming available. In addition, replacing immunological monitoring with virological monitoring in non-viremic patients in a phased manner will reduce the costs associated with dual immuno-virological monitoring. Going forward, the simplification of testing paired with price reducing strategies that will allow for healthy competition between multiple manufacturers will enable the implementation of viral load testing in resource-poor settings. It is important that future HIV and AIDS treatment guidelines provide clear recommendations for routine virological monitoring and that governments and donors fund the implementation of accurate and operationally proven testing platforms in a comprehensive manner.</description>
      <pubDate>Tue, 09 Oct 2012 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10144/280932</guid>
      <dc:date>2012-10-09T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Use of filter paper as a transport medium for laboratory diagnosis of cholera under field conditions</title>
      <link>http://hdl.handle.net/10144/242391</link>
      <description>Title: Use of filter paper as a transport medium for laboratory diagnosis of cholera under field conditions
Authors: Page, Anne-Laure; Alberti, Kathryn P; Guénolé, Alain; Mondongue, Vital; Lonlas Mayele, Sylvaine; Guerin, Philippe J; Quilici, Marie-Laure
Abstract: Confirmation of a cholera epidemic is based on bacteriological identification of the agent and requires the sending of samples to a culture laboratory, often in countries with limited resources. Comparison of the use of filter paper with the use of Cary-Blair reference medium for stool transport showed that this simple transport medium is appropriate for the recovery of Vibrio cholerae.</description>
      <pubDate>Wed, 22 Jun 2011 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10144/242391</guid>
      <dc:date>2011-06-22T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Evaluation of four rapid tests for diagnosis and differentiation of HIV-1 and HIV-2 infections in Guinea-Conakry, West Africa.</title>
      <link>http://hdl.handle.net/10144/112714</link>
      <description>Title: Evaluation of four rapid tests for diagnosis and differentiation of HIV-1 and HIV-2 infections in Guinea-Conakry, West Africa.
Authors: Chaillet, Pascale; Tayler-Smith, Katie; Zachariah, Rony; Duclos, Nanfack; Moctar, Diallo; Beelaert, Greet; Fransen, Katrien
Abstract: With both HIV-1 and HV-2 prevalent in Guinea-Conakry, accurate diagnosis and differentiation is crucial for treatment purposes. Thus, four rapid HIV tests were evaluated for their HIV-1 and HIV-2 diagnostic and discriminative capacity for use in Guinea-Conakry. These included SD Bioline HIV 1/2 3.0 (Standard Diagnostics Inc.), Genie II HIV1/HIV2 (Bio-Rad), First Response HIV Card Test 1-2.0 (PMC Medical) and Immunoflow HIV1-HIV2 (Core Diagnostics). Results were compared with gold standard tests (INNO-LIA HIV-I/II Score) and NEW LAV BLOT II (Bio-Rad). Four hundred and forty three sequential stored HIV-positive serum samples, of known HIV-type, were evaluated. Genie II HIV1/HIV2, Immunoflow HIV1-HIV2 and SD Bioline HIV 1/2 3.0 had 100% sensitivity (95% CI, 98.9-100%) while for First Response HIV Card Test 1-2.0 this was 99.5% (95% CI, 98.2%-99.9%). In terms of discriminatory capacity, Genie II HIV1/HIV2 identified 382/ 384(99.5%) HIV-1 samples, 49/ 52(95%) HIV-2 and 7/7(100%) HIV-positive untypable samples. Immunoflow HIV1-HIV2 identified 99% HIV-1, 67% HIV-2 and all HIV-positive untypable samples. First Response HIV Card Test 1-2.0 identified 94% HIV-1, 64% HIV-2 and 57% HIV-positive untypable samples. SD-Bioline HIV 1/2 3.0 was the worst overall performer identifying 65% HIV-1, 69% HIV-2 and all HIV-positive untypable samples. The use of SD Bioline HIV 1/2 3.0 (the current standard in Guinea-Conakry) as a discriminatory HIV test is poor and may be best replaced by Immunoflow HIV1-HIV2.</description>
      <pubDate>Wed, 01 Sep 2010 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10144/112714</guid>
      <dc:date>2010-09-01T00:00:00Z</dc:date>
    </item>
    <item>
      <title>Outbreak of hepatitis E virus infection in Darfur, Sudan: effectiveness of real-time reverse transcription-PCR analysis of dried blood spots</title>
      <link>http://hdl.handle.net/10144/114152</link>
      <description>Title: Outbreak of hepatitis E virus infection in Darfur, Sudan: effectiveness of real-time reverse transcription-PCR analysis of dried blood spots
Authors: Mérens, Audrey; Guérin, Philippe Jean; Guthmann, Jean-Paul; Nicand, Elisabeth
Abstract: Biological samples collected in refugee camps during an outbreak of hepatitis E were used to compare the accuracy of hepatitis E virus RNA amplification by real-time reverse transcription-PCR (RT-PCR) for sera and dried blood spots (concordance of 90.6%). Biological profiles (RT-PCR and serology) of asymptomatic individuals were also analyzed.</description>
      <pubDate>Wed, 01 Apr 2009 00:00:00 GMT</pubDate>
      <guid isPermaLink="false">http://hdl.handle.net/10144/114152</guid>
      <dc:date>2009-04-01T00:00:00Z</dc:date>
    </item>
  </channel>
</rss>

